HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanyan Jiang Selected Research

Hyaluronic Acid (Hyaluronan)

9/2020Efficiency of Different Treatment Regimens Combining Anti-tumor and Anti-inflammatory Liposomes for Metastatic Breast Cancer.
1/2019Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yanyan Jiang Research Topics

Disease

51Neoplasms (Cancer)
12/2022 - 12/2007
10Inflammation (Inflammations)
01/2022 - 08/2006
9Breast Neoplasms (Breast Cancer)
01/2022 - 09/2010
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 03/2014
5Cardiotoxicity
09/2022 - 05/2020
5Neoplasm Metastasis (Metastasis)
08/2022 - 01/2017
5Lung Neoplasms (Lung Cancer)
01/2021 - 03/2014
5Body Weight (Weight, Body)
01/2021 - 10/2014
4Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 03/2020
4Glioma (Gliomas)
01/2017 - 10/2011
4Hypoxia (Hypoxemia)
01/2016 - 08/2012
3Heart Failure
02/2022 - 01/2015
3Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2020
3Multiple System Atrophy
01/2022 - 01/2021
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2018 - 07/2015
3Ovarian Neoplasms (Ovarian Cancer)
08/2018 - 11/2014
3Infections
01/2018 - 04/2009
3Pre-Eclampsia (Preeclampsia)
05/2012 - 10/2009
3Brain Injuries (Brain Injury)
10/2008 - 08/2007
2Triple Negative Breast Neoplasms
08/2022 - 01/2019
2Type 2 Diabetes Mellitus (MODY)
05/2022 - 12/2018
2Coronary Disease (Coronary Heart Disease)
02/2022 - 02/2021
2Hyperlipidemias (Hyperlipidemia)
01/2022 - 05/2021
2Acute Promyelocytic Leukemia
09/2021 - 11/2020
2Myocardial Infarction
02/2021 - 01/2020
2Brain Neoplasms (Brain Tumor)
01/2017 - 10/2011
2Carcinoma (Carcinomatosis)
03/2016 - 11/2014
2Schistosomiasis (Bilharziasis)
01/2016 - 01/2015
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2010 - 04/2009
2Hypertension (High Blood Pressure)
10/2009 - 08/2009
2Leukocytosis (Pleocytosis)
10/2008 - 08/2007
2Central Nervous System Diseases (CNS Diseases)
12/2007 - 08/2007
1Urinary Bladder Neoplasms (Bladder Cancer)
12/2022

Drug/Important Bio-Agent (IBA)

18Pharmaceutical PreparationsIBA
09/2022 - 01/2009
15Doxorubicin (Adriamycin)FDA LinkGeneric
09/2022 - 01/2010
11Biomarkers (Surrogate Marker)IBA
02/2022 - 08/2006
8PolymersIBA
10/2018 - 10/2011
8AlbuminsIBA
10/2018 - 11/2014
7Liposomes (Liposome)IBA
08/2022 - 10/2008
7Proteins (Proteins, Gene)FDA Link
08/2022 - 12/2007
6CytokinesIBA
03/2020 - 01/2015
5DNA (Deoxyribonucleic Acid)IBA
09/2022 - 11/2013
5Peptides (Polypeptides)IBA
09/2020 - 12/2007
4MicroRNAs (MicroRNA)IBA
02/2022 - 12/2019
4Biological ProductsIBA
01/2022 - 07/2015
4Messenger RNA (mRNA)IBA
01/2018 - 10/2008
4IntegrinsIBA
01/2017 - 10/2011
4PAMAM StarburstIBA
05/2015 - 01/2010
4ChemokinesIBA
07/2010 - 08/2007
3Gefitinib (Iressa)FDA Link
09/2022 - 03/2014
3AntibodiesIBA
08/2022 - 01/2015
3Dacarbazine (DIC)FDA LinkGeneric
03/2021 - 05/2020
3CurcuminIBA
09/2020 - 03/2016
3ISIS 5132IBA
10/2018 - 11/2014
3MicellesIBA
03/2016 - 11/2014
3AcidsIBA
05/2015 - 02/2010
3Poly(amidoamine)IBA
05/2015 - 02/2010
3Transferrin (beta 2 Transferrin)IBA
01/2010 - 12/2007
2danqi tongmaiIBA
02/2022 - 02/2021
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 11/2017
2Arsenic Trioxide (Trisenox)FDA Link
09/2021 - 11/2020
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2021 - 01/2016
2olaparibIBA
01/2021 - 01/2016
2Hyaluronic Acid (Hyaluronan)IBA
09/2020 - 01/2019
2Transforming Growth Factor beta (TGF-beta)IBA
03/2020 - 08/2012
2VaccinesIBA
01/2020 - 01/2015
2AntigensIBA
01/2020 - 01/2016
2Estrogens (Estrogen)FDA Link
10/2019 - 08/2009
2OligonucleotidesIBA
10/2018 - 07/2015
2poly(2-(dimethylamino)ethyl methacrylate)IBA
10/2018 - 07/2015
2Radiation-Sensitizing AgentsIBA
01/2018 - 01/2016
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018 - 01/2016
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2018 - 01/2016
2LeptinIBA
01/2018 - 10/2014
2polycaprolactoneIBA
12/2017 - 03/2016
2Neuropilin-1IBA
01/2017 - 10/2014
2poly(lactide) (polylactic acid)IBA
01/2017 - 11/2013
2Carmustine (FIVB)FDA Link
01/2017 - 11/2013
2ChitosanIBA
01/2017 - 11/2013
2Atrial Natriuretic Factor (ANF)IBA
09/2016 - 01/2015
2interleukin-21 (interleukin 21)IBA
01/2016 - 01/2015
2Leptin ReceptorsIBA
01/2016 - 10/2014
2Histones (Histone)IBA
11/2015 - 12/2013
2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
05/2015 - 01/2009
2Tyrosine Kinase InhibitorsIBA
07/2014 - 03/2014
2EnzymesIBA
05/2012 - 10/2009
2Nitric Oxide Synthase (NO Synthase)IBA
05/2012 - 10/2009
2PEG-PAMAMIBA
10/2011 - 03/2011
2homocamptothecinIBA
01/2010 - 01/2009
2hydroxycamptothecinumIBA
01/2010 - 01/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2009 - 12/2007
2Transferrin Receptors (Transferrin Receptor)IBA
01/2009 - 12/2007
1Immune Checkpoint InhibitorsIBA
12/2022
1RNA (Ribonucleic Acid)IBA
12/2022
1Drug CombinationsIBA
09/2022
1Monophenol Monooxygenase (Tyrosinase)IBA
09/2022

Therapy/Procedure

25Therapeutics
12/2022 - 12/2007
4Drug Therapy (Chemotherapy)
09/2022 - 01/2020
4Radiotherapy
01/2021 - 03/2014
2Immunotherapy
08/2022 - 01/2020